Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Am J Perinatol. 2021 Nov 16;40(14):1585–1589. doi: 10.1055/s-0041-1739354

Fig. 4. Schematic of proposed mechanism of 17-OHPC.

Fig. 4

17-OHPC injections modulate the IL-10 leukocyte immune response to inflammatory stimulus which allows for mitigation of inflammation-induced preterm birth. IL-10, interleukin-10; TNF-α, tumor necrosis factor alpha; 17-OHPC, 17α-hydroxyprogesterone caproate. Created with BioRender.com.